3Cooper C, Campion G, Melton LJm. Hip fractures in the elderly : a world-wide projection[ J ]. Osteoporos Int. 1992 ; 2(6) :285 -289.
4Cao Y, Moil S, Mashiba T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats[ J]. J Bone Miner Res, 2002, 17(12) :2237 -2246.
5Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study [ J ]. J Clin Invest, 1988,81 (6) : 1804 - 1809.
6Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture [ J ]. JAMA, 2001,285:320 - 323.
7Turner CH. Biomechanics of bone: determinants of skeletal fragility and bone quality [ J]. Osteoporos Int, 2002, 13 (2) :97 - 104.
8Krolner B, Toft B, Pors Nielsen S, et al. Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial[J]. Clin Sci (Lond), 1983,64(5) :541 - 546.
9Tsakalakos N, Magiasis B, Tsekoura M, et al. The effect of short-term calcitonin administration on biochemical bone markers in patients with acute immobilization following hip fracture[J]. Osteoporos Int, 1993,3(6) :337 -340.
10Karachalios T, Lyritis GP, Kaloudis J, et al. The effects of calcitonin on acute bone loss after pertrochanteric fractures [J]. J Bone Joint Surg(Br) ,2004,86 -B:350 -358.
